CCCC - C4 Therapeutics Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 2024-08-05    (Delayed quote data   2025-01-06)
Last
 4.09		 Change
 ⇑ +0.17   (+4.34%)		 Volume
  1,253,476
Open
 4.01		 High
 4.26		 Low
 3.92
8EMA (Daily)
 3.88		 40EMA (Daily)
 4.36		 50EMA (Daily)
 4.51		 STO (Daily)
 28.478		 MACD Hist (Daily)
 0.081
8EMA (Weekly)
 4.273		 40EMA (Weekly)
 5.21		 50EMA (Weekly)
 5.32		 STO (Weekly)
 12.682		 MACD Hist (Weekly)
 -0.273
Company Profile
C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com